Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05954871
Title Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN | AUS

Facility Status City State Zip Country Details
Yale Cancer Center RECRUITING New Haven Connecticut 06519 United States Details
Christiana Care Health System RECRUITING Newark Delaware 19713 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
START South Texas Accelerated Research Therapeutics-San Antonio RECRUITING San Antonio Texas 78229 United States Details
Border Medical Oncology RECRUITING Wodonga New South Wales 3690 Australia Details
The Queen Elizabeth Hospital RECRUITING Woodville South Australia 5011 Australia Details
St Vincent's Hospital Melbourne RECRUITING Fitzroy Victoria 3065 Australia Details
Ottawa Hospital RECRUITING Ottawa Ontario K1H 8L6 Canada Details
Seoul National University Hospital RECRUITING Seoul 03080 Korea, Republic of Details
Asan Medical Center RECRUITING Seoul 05505 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field